{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T06:40:38Z","timestamp":1792737638053,"version":"4.5.0"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T00:00:00Z","timestamp":1761004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T00:00:00Z","timestamp":1761004800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neuroinflammation"],"DOI":"10.1186\/s12974-025-03567-4","type":"journal-article","created":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T11:43:27Z","timestamp":1761047007000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Exosomal pHERV-W ENV as a dynamic biomarker for relapse prediction and prognosis in multiple sclerosis"],"prefix":"10.1186","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1525-6394","authenticated-orcid":false,"given":"Esber S.","family":"Saba","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4379-5862","authenticated-orcid":false,"given":"May F.","family":"Mrad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7784-7416","authenticated-orcid":false,"given":"Layane","family":"Nakib","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-9508-0108","authenticated-orcid":false,"given":"Vera","family":"Dermesrobian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-2850-8551","authenticated-orcid":false,"given":"Joseph","family":"Abboud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3198-6063","authenticated-orcid":false,"given":"Samia J.","family":"Khoury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,21]]},"reference":[{"issue":"1","key":"3567_CR1","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1111\/ene.13819","volume":"26","author":"R Dobson","year":"2019","unstructured":"Dobson R, Giovannoni G. Multiple sclerosis - a review. Eur J Neurol. 2019;26(1):27\u201340. https:\/\/doi.org\/10.1111\/ene.13819.","journal-title":"Eur J Neurol"},{"issue":"7900","key":"3567_CR2","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1038\/s41586-022-04432-7","volume":"603","author":"TV Lanz","year":"2022","unstructured":"Lanz TV, Brewer RC, Ho PP, Moon JS, Jude KM, Fernandez D, et al. Clonally expanded B cells in multiple sclerosis bind EBV EBNA1 and glialcam. Nature. 2022;603(7900):321\u20137. https:\/\/doi.org\/10.1038\/s41586-022-04432-7.","journal-title":"Nature"},{"issue":"3","key":"3567_CR3","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1038\/s41582-023-00775-5","volume":"19","author":"K Bjornevik","year":"2023","unstructured":"Bjornevik K, M\u00fcnz C, Cohen JI, Ascherio A. Epstein\u2013Barr virus as a leading cause of multiple sclerosis: mechanisms and implications. Nat Rev Neurol. 2023;19(3):160\u201371. https:\/\/doi.org\/10.1038\/s41582-023-00775-5.","journal-title":"Nat Rev Neurol"},{"issue":"2","key":"3567_CR4","doi-asserted-by":"publisher","first-page":"e0172415","DOI":"10.1371\/journal.pone","volume":"12","author":"E Morandi","year":"2017","unstructured":"Morandi E, Tanasescu R, Tarlinton RE, Constantinescu CS, Zhang W, Tench C, et al. The association between human endogenous retroviruses and multiple sclerosis: A systematic review and meta-analysis. PLoS ONE. 2017;12(2):e0172415. https:\/\/doi.org\/10.1371\/journal.pone.","journal-title":"PLoS ONE"},{"issue":"4","key":"3567_CR5","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/j.molmed.2018.02.007","volume":"24","author":"P K\u00fcry","year":"2018","unstructured":"K\u00fcry P, Nath A, Cr\u00e9ange A, Dolei A, Marche P, Gold J, et al. Human endogenous retroviruses in neurological diseases. Trends Mol Med. 2018;24(4):379\u201394. https:\/\/doi.org\/10.1016\/j.molmed.2018.02.007.","journal-title":"Trends Mol Med"},{"issue":"4","key":"3567_CR6","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1007\/s13365-024-01208-9","volume":"30","author":"T Nevalainen","year":"2024","unstructured":"Nevalainen T, Autio-Kimura A, Hurme M. Human endogenous retrovirus W in multiple sclerosis: transcriptional activity is associated with decline in oligodendrocyte proportions in the white matter of the brain. J Neurovirol. 2024;30(4):393\u2013405. https:\/\/doi.org\/10.1007\/s13365-024-01208-9.","journal-title":"J Neurovirol"},{"issue":"5\u20136","key":"3567_CR7","doi-asserted-by":"publisher","first-page":"105382","DOI":"10.1016\/j.micinf.2024","volume":"27","author":"J Gruchot","year":"2025","unstructured":"Gruchot J, Reiche L, Werner L, Herrero F, Schira-Heinen J, Meyer U, et al. Molecular dissection of HERV-W dependent microglial- and astroglial cell polarization. Microbes Infect. 2025;27(5\u20136):105382. https:\/\/doi.org\/10.1016\/j.micinf.2024.","journal-title":"Microbes Infect"},{"issue":"30","key":"3567_CR8","doi-asserted-by":"publisher","first-page":"15216","DOI":"10.1073\/pnas.1901283116","volume":"116","author":"D Kremer","year":"2019","unstructured":"Kremer D, Gruchot J, Weyers V, Oldemeier L, Gottle P, Healy L, et al. PHerv-w envelope protein fuels microglial cell-dependent damage of myelinated axons in multiple sclerosis. Proc Natl Acad Sci U S A. 2019;116(30):15216\u201325. https:\/\/doi.org\/10.1073\/pnas.1901283116.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"38","key":"3567_CR9","doi-asserted-by":"publisher","first-page":"e2308187120","DOI":"10.1073\/pnas","volume":"120","author":"J Gruchot","year":"2023","unstructured":"Gruchot J, Lewen I, Dietrich M, Reiche L, Sindi M, Hecker C, et al. Transgenic expression of the HERV-W envelope protein leads to polarized glial cell populations and a neurodegenerative environment. Proc Natl Acad Sci U S A. 2023;120(38):e2308187120. https:\/\/doi.org\/10.1073\/pnas.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"3567_CR10","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1007\/s12250-021-00372-0","volume":"36","author":"B Charvet","year":"2021","unstructured":"Charvet B, Pierquin J, Brunel J, Gorter R, Quetard C, Horvat B, et al. Human endogenous retrovirus type W envelope from multiple sclerosis demyelinating lesions shows unique solubility and antigenic characteristics. Virol Sin. 2021;36(5):1006\u201326. 10.7\/s12250-021-00372-0.","journal-title":"Virol Sin"},{"issue":"12","key":"3567_CR11","doi-asserted-by":"publisher","first-page":"1721","DOI":"10.1177\/1352458512441381","volume":"18","author":"H Perron","year":"2012","unstructured":"Perron H, Germi R, Bernard C, Garcia-Montojo M, Deluen C, Farinelli L, et al. Human endogenous retrovirus type W envelope expression in blood and brain cells provides new insights into multiple sclerosis disease. Mult Scler. 2012;18(12):1721\u201336. 10.177\/1352458512441381.","journal-title":"Mult Scler"},{"key":"3567_CR12","doi-asserted-by":"publisher","first-page":"1505239","DOI":"10.3389\/fimmu.2024","volume":"15","author":"S Ruberto","year":"2025","unstructured":"Ruberto S, Dom\u0131nguez-Mozo MI, Garc\u0131a-Mart\u0131nez MA, Cossu D, Sechi LA, Alvarez-Lafuente R. Immune response profiling of HERV-W envelope proteins in multiple sclerosis: potential biomarkers for disease progression. Front Immunol. 2025;15:1505239. https:\/\/doi.org\/10.3389\/fimmu.2024.","journal-title":"Front Immunol"},{"issue":"9","key":"3567_CR13","doi-asserted-by":"publisher","first-page":"e44991","DOI":"10.1371\/journal.pone.0044991","volume":"7","author":"G Mameli","year":"2012","unstructured":"Mameli G, Poddighe L, Mei A, Uleri E, Sotgiu S, Serra C, et al. Expression and activation by Epstein Barr virus of human endogenous retroviruses-W in blood cells and astrocytes: inference for multiple sclerosis. PLoS ONE. 2012;7(9):e44991. https:\/\/doi.org\/10.1371\/journal.pone.0044991.","journal-title":"PLoS ONE"},{"issue":"11","key":"3567_CR14","doi-asserted-by":"publisher","first-page":"e78474","DOI":"10.1371\/journal.pone.0078474","volume":"8","author":"G Mameli","year":"2013","unstructured":"Mameli G, Madeddu G, Mei A, Uleri E, Poddighe L, Delogu LG, et al. Activation of MSRV-type endogenous retroviruses during infectious mononucleosis and Epstein-Barr virus latency: the missing link with multiple sclerosis? PLoS ONE. 2013;8(11):e78474. https:\/\/doi.org\/10.1371\/journal.pone.0078474.","journal-title":"PLoS ONE"},{"issue":"1","key":"3567_CR15","doi-asserted-by":"publisher","first-page":"14293","DOI":"10.1038\/s41598-017-14301-3","volume":"7","author":"S Ebrahimkhani","year":"2017","unstructured":"Ebrahimkhani S, Vafaee F, Young PE, Hur SSJ, Hawke S, Devenney E, et al. Exosomal microrna signatures in multiple sclerosis reflect disease status. Sci Rep. 2017;7(1):14293. https:\/\/doi.org\/10.1038\/s41598-017-14301-3.","journal-title":"Sci Rep"},{"key":"3567_CR16","doi-asserted-by":"publisher","first-page":"1613618","DOI":"10.3389\/fncel.2025","volume":"19","author":"C Palazzo","year":"2025","unstructured":"Palazzo C, Asci I, Russo S, Buccoliero C, Mangialardi V, Abbrescia P, et al. Circulating exosomes with unique lipid signature in relapsing remitting multiple sclerosis. Front Cell Neurosci. 2025;19:1613618. https:\/\/doi.org\/10.3389\/fncel.2025.","journal-title":"Front Cell Neurosci"},{"issue":"7","key":"3567_CR17","doi-asserted-by":"publisher","first-page":"1733","DOI":"10.3390\/cells10071733","volume":"10","author":"M D\u2019Anca","year":"2021","unstructured":"D\u2019Anca M, Fenoglio C, Buccellato FR, Visconte C, Galimberti D, Scarpini E. Extracellular vesicles in multiple sclerosis: role in the pathogenesis and potential usefulness as biomarkers and therapeutic tools. Cells. 2021;10(7):1733. https:\/\/doi.org\/10.3390\/cells10071733.","journal-title":"Cells"},{"issue":"10","key":"3567_CR18","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.7150\/ijbs.19531","volume":"13","author":"SY Teow","year":"2017","unstructured":"Teow SY, Liew K, Khoo AS, Peh SC. Pathogenic role of exosomes in Epstein-Barr virus (EBV)-associated cancers. Int J Biol Sci. 2017;13(10):1276\u201386. https:\/\/doi.org\/10.7150\/ijbs.19531.","journal-title":"Int J Biol Sci"},{"key":"3567_CR19","doi-asserted-by":"publisher","first-page":"757302","DOI":"10.3389\/fimmu.2021","volume":"12","author":"UC Meier","year":"2021","unstructured":"Meier UC, Cipian RC, Karimi A, Ramasamy R, Middeldorp JM. Cumulative roles for Epstein-Barr virus, human endogenous retroviruses, and human herpes virus-6 in driving an inflammatory cascade underlying MS pathogenesis. Front Immunol. 2021;12:757302. https:\/\/doi.org\/10.3389\/fimmu.2021.","journal-title":"Front Immunol"},{"issue":"4","key":"3567_CR20","doi-asserted-by":"publisher","first-page":"e1004","DOI":"10.1212\/NXI.0000000000001004","volume":"8","author":"MF Mrad","year":"2021","unstructured":"Mrad MF, Saba ES, Nakib L, Khoury SJ. Exosomes from subjects with multiple sclerosis express EBV-derived proteins and activate monocyte-derived macrophages. Neurol Neuroimmunol Neuroinflamm. 2021;8(4):e1004. 10.212\/NXI.0000000000001004.","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"2","key":"3567_CR21","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/S474-4422(17)30470-2","volume":"17","author":"AJ Thompson","year":"2018","unstructured":"Thompson AJ, Banwell BL, Barkhof F, Carroll WM, Coetzee T, Comi G, et al. Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurol. 2018;17(2):162\u201373. https:\/\/doi.org\/10.1016\/S474-4422(17)30470-2.","journal-title":"Lancet Neurol"},{"issue":"9","key":"3567_CR22","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1177\/1352458514560926","volume":"21","author":"D Kremer","year":"2015","unstructured":"Kremer D, Forster M, Schichel T, Gottle P, Hartung HP, Perron H, et al. The neutralizing antibody GNbAC1 abrogates HERV-W envelope protein-mediated oligodendroglial maturation Blockade. Mult Scler. 2015;21(9):1200\u20133. 10.177\/1352458514560926.","journal-title":"Mult Scler"},{"issue":"3","key":"3567_CR23","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1177\/13524585211024997","volume":"28","author":"HP Hartung","year":"2022","unstructured":"Hartung HP, Derfuss T, Cree BA, Sormani MP, Selmaj K, Stutters J, et al. Efficacy and safety of Temelimab in multiple sclerosis: results of a randomized phase 2b and extension study. Mult Scler. 2022;28(3):429\u201340. https:\/\/doi.org\/10.1177\/13524585211024997.","journal-title":"Mult Scler"},{"issue":"7","key":"3567_CR24","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1111\/dom.14010","volume":"22","author":"F Curtin","year":"2020","unstructured":"Curtin F, Champion B, Davoren P, Duke S, Ekinci EI, Gilfillan C, et al. A safety and pharmacodynamics study of temelimab, an antipathogenic human endogenous retrovirus type W envelope monoclonal antibody, in patients with type 1 diabetes. Diabetes Obes Metab. 2020;22(7):1111\u201321. 10.\/dom.14010.","journal-title":"Diabetes Obes Metab"},{"issue":"4","key":"3567_CR25","doi-asserted-by":"publisher","first-page":"415","DOI":"10.3390\/vaccines13040415","volume":"13","author":"ER Simula","year":"2025","unstructured":"Simula ER, Jasemi S, Cossu D, Fais M, Cossu I, Chessa V, et al. Human endogenous retroviruses as novel therapeutic targets in neurodegenerative disorders. Vaccines. 2025;13(4):415. https:\/\/doi.org\/10.3390\/vaccines13040415.","journal-title":"Vaccines"},{"issue":"1","key":"3567_CR26","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1038\/s41389-018-0114-y","volume":"8","author":"J Chen","year":"2019","unstructured":"Chen J, Foroozesh M, Qin Z. Transactivation of human endogenous retroviruses by tumor viruses and their functions in virus-associated malignancies. Oncogenesis. 2019;8(1):6. https:\/\/doi.org\/10.1038\/s41389-018-0114-y.","journal-title":"Oncogenesis"},{"issue":"1","key":"3567_CR27","doi-asserted-by":"publisher","first-page":"233","DOI":"10.31083\/j.jin.2021.01.392","volume":"20","author":"C Br\u00fctting","year":"2021","unstructured":"Br\u00fctting C, Stangl G, Staege M, Vitamin D. Epstein-Barr virus, and endogenous retroviruses in multiple sclerosis - facts and hypotheses. J Integr Neurosci. 2021;20(1):233\u20138. https:\/\/doi.org\/10.31083\/j.jin.2021.01.392.","journal-title":"J Integr Neurosci"},{"key":"3567_CR28","doi-asserted-by":"publisher","first-page":"103318","DOI":"10.1016\/j.msard.2021","volume":"57","author":"T Latifi","year":"2022","unstructured":"Latifi T, Zebardast A, Marashi SM. The role of human endogenous retroviruses (HERVs) in multiple sclerosis and the plausible interplay between HERVs, Epstein-Barr virus infection, and vitamin D. Mult Scler Relat Disord. 2022;57:103318. https:\/\/doi.org\/10.1016\/j.msard.2021.","journal-title":"Mult Scler Relat Disord"},{"key":"3567_CR29","doi-asserted-by":"publisher","first-page":"777542","DOI":"10.3389\/fncel.2021","volume":"15","author":"P Gottle","year":"2021","unstructured":"Gottle P, Schichel K, Reiche L, Werner L, Zink A, Prigione A, et al. TLR4 associated signaling disrupters as a new means to overcome HERV-W envelope-mediated myelination deficits. Front Cell Neurosci. 2021;15:777542. https:\/\/doi.org\/10.3389\/fncel.2021.","journal-title":"Front Cell Neurosci"},{"issue":"21","key":"3567_CR30","doi-asserted-by":"publisher","first-page":"15635","DOI":"10.3390\/ijms242115635","volume":"24","author":"Z Osaid","year":"2023","unstructured":"Osaid Z, Haider M, Hamoudi R, Harati R. Exosomes interactions with the blood\u2013brain barrier: implications for cerebral disorders and therapeutics. Int J Mol Sci. 2023;24(21):15635. https:\/\/doi.org\/10.3390\/ijms242115635.","journal-title":"Int J Mol Sci"},{"issue":"6","key":"3567_CR31","doi-asserted-by":"publisher","DOI":"10.3390\/ph14060495","volume":"14","author":"K Gimenez-Orenga","year":"2021","unstructured":"Gimenez-Orenga K, Oltra E. Human endogenous retrovirus as therapeutic targets in neurologic disease. Pharmaceuticals (Basel). 2021;14(6):495. https:\/\/doi.org\/10.3390\/ph14060495.","journal-title":"Pharmaceuticals (Basel)"},{"issue":"6","key":"3567_CR32","doi-asserted-by":"publisher","first-page":"745","DOI":"10.3390\/genes15060745","volume":"15","author":"GL Adler","year":"2024","unstructured":"Adler GL, Le K, Fu Y, Kim WS. Human endogenous retroviruses in neurodegenerative diseases. Genes. 2024;15(6):745. https:\/\/doi.org\/10.3390\/genes15060745.","journal-title":"Genes"},{"key":"3567_CR33","doi-asserted-by":"publisher","unstructured":"Bhetariya PJ, Kriesel JD, Fischer KF. Analysis of human endogenous retrovirus expression in multiple sclerosis plaques. J Emerg Dis Virol. 2017;3(2). https:\/\/doi.org\/10.16966\/2473-1846.133.","DOI":"10.16966\/2473-1846.133"},{"issue":"3","key":"3567_CR34","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1089\/aid.2007.0196","volume":"24","author":"DL Moyes","year":"2008","unstructured":"Moyes DL, Goris A, Ban M, Compston A, Griffiths DJ, Sawcer S, et al. HERV-K113 is not associated with multiple sclerosis in a large family-based study. AIDS Res Hum Retroviruses. 2008;24(3):363\u20135. https:\/\/doi.org\/10.1089\/aid.2007.0196.","journal-title":"AIDS Res Hum Retroviruses"},{"key":"3567_CR35","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1186\/742-4690-6-104","volume":"6","author":"T Brudek","year":"2009","unstructured":"Brudek T, Christensen T, Aagaard L, Petersen T, Hansen HJ, M\u00f8ller-Larsen A. B cells and monocytes from patients with active multiple sclerosis exhibit increased surface expression of both HERV-H Env and HERV-W Env, accompanied by increased seroreactivity. Retrovirology. 2009;6:104. https:\/\/doi.org\/10.1186\/742-4690-6-104.","journal-title":"Retrovirology"},{"issue":"7","key":"3567_CR36","doi-asserted-by":"publisher","first-page":"3713","DOI":"10.1128\/JVI.06723-11","volume":"86","author":"MJ Laska","year":"2012","unstructured":"Laska MJ, Brudek T, Nissen KK, Christensen T, Moller-Larsen A, Petersen T, et al. Expression of HERV-Fc1, a human endogenous retrovirus, is increased in patients with active multiple sclerosis. J Virol. 2012;86(7):3713\u201322. https:\/\/doi.org\/10.1128\/JVI.06723-11.","journal-title":"J Virol"},{"key":"3567_CR37","doi-asserted-by":"publisher","first-page":"102392","DOI":"10.1016\/j.arr.2024","volume":"99","author":"ST Censi","year":"2024","unstructured":"Censi ST, Mariani-Costantini R, Granzotto A, Tomassini V, Sensi SL. Endogenous retroviruses in multiple sclerosis: A network-based etiopathogenic model. Ageing Res Rev. 2024;99:102392. https:\/\/doi.org\/10.1016\/j.arr.2024.","journal-title":"Ageing Res Rev"},{"issue":"2","key":"3567_CR38","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1111\/imm.13712","volume":"171","author":"S Ruberto","year":"2024","unstructured":"Ruberto S, Cossu D, Sechi LA. Correlation between antibodies against the pathogenic pHERV-W envelope protein and the inflammatory phase of multiple sclerosis. Immunology. 2024;171(2):270\u20136. https:\/\/doi.org\/10.1111\/imm.13712.","journal-title":"Immunology"},{"issue":"7","key":"3567_CR39","doi-asserted-by":"publisher","first-page":"e70501","DOI":"10.1002\/jmv","volume":"97","author":"L Lyu","year":"2025","unstructured":"Lyu L, Li Q, Wang C. EBV latency programs: molecular and epigenetic regulation and its role in disease pathogenesis. J Med Virol. 2025;97(7):e70501. https:\/\/doi.org\/10.1002\/jmv.","journal-title":"J Med Virol"},{"key":"3567_CR40","doi-asserted-by":"publisher","first-page":"1791","DOI":"10.3389\/fimmu.2017.01791","volume":"8","author":"SABM Aarts","year":"2017","unstructured":"Aarts SABM, Seijkens TTP, Dorst KJFv, Dijkstra CD, Kooij G, Lutgens E. The CD40\u2013CD40L dyad in experimental autoimmune encephalomyelitis and multiple sclerosis. Front Immunol. 2017;8:1791. https:\/\/doi.org\/10.3389\/fimmu.2017.01791.","journal-title":"Front Immunol"},{"key":"3567_CR41","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1007\/s11940-024-00818-2","volume":"27","author":"P Vermersch","year":"2025","unstructured":"Vermersch P, Wagner D, Mars LT, Noelle R, Giovannoni G. Inhibiting CD40 ligand in multiple sclerosis: a review of emerging therapeutic potential. Curr Treat Options Neurol. 2025;27:7. https:\/\/doi.org\/10.1007\/s11940-024-00818-2.","journal-title":"Curr Treat Options Neurol"},{"key":"3567_CR42","doi-asserted-by":"publisher","first-page":"620963","DOI":"10.3389\/fimmu.2021","volume":"12","author":"JM Orian","year":"2021","unstructured":"Orian JM, D\u2019Souza CS, Kocovski P, Krippner G, Hale MW, Wang X, et al. Platelets in multiple sclerosis: early and central mediators of inflammation and neurodegeneration and attractive targets for molecular imaging and site-directed therapy. Front Immunol. 2021;12:620963. https:\/\/doi.org\/10.3389\/fimmu.2021.","journal-title":"Front Immunol"},{"issue":"8","key":"3567_CR43","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1182\/blood.2022015970","volume":"140","author":"T Burnouf","year":"2022","unstructured":"Burnouf T, Walker TL. The multifaceted role of platelets in mediating brain function. Blood. 2022;140(8):815\u201327. https:\/\/doi.org\/10.1182\/blood.2022015970.","journal-title":"Blood"},{"issue":"Suppl 1","key":"3567_CR44","doi-asserted-by":"publisher","first-page":"A210","DOI":"10.1186\/742-4690-8-S1-A210","volume":"8","author":"T Brudek","year":"2011","unstructured":"Brudek T, Christensen T, Petersen T, M\u00f8ller-Larsen A. Expression of HERV-H\/W Env epitopes on PBMCs from MS patients with active disease. Retrovirology. 2011;8(Suppl 1):A210. https:\/\/doi.org\/10.1186\/742-4690-8-S1-A210.","journal-title":"Retrovirology"},{"key":"3567_CR45","doi-asserted-by":"publisher","first-page":"591894","DOI":"10.3389\/fneur.2020","volume":"11","author":"R Chunder","year":"2020","unstructured":"Chunder R, Schropp V, Kuerten S. B cells in multiple sclerosis and virus-induced neuroinflammation. Front Neurol. 2020;11:591894. https:\/\/doi.org\/10.3389\/fneur.2020.","journal-title":"Front Neurol"},{"issue":"5","key":"3567_CR46","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1002\/eji.201948423","volume":"50","author":"M Garcia-Montojo","year":"2020","unstructured":"Garcia-Montojo M, Rodr\u00edguez-Mart\u00edn E, Ramos-Mozo P, Ortega-Madue\u00f1o I, Dom\u00ednguez-Mozo M, Arias-Leal A, et al. Syncytin\u20101\/HERV\u2010W envelope is an early activation marker of leukocytes and is upregulated in multiple sclerosis patients. Eur J Immunol. 2020;50(5):685\u201394. https:\/\/doi.org\/10.1002\/eji.201948423.","journal-title":"Eur J Immunol"},{"issue":"12","key":"3567_CR47","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21124407","volume":"21","author":"WA Banks","year":"2020","unstructured":"Banks WA, Sharma P, Bullock KM, Hansen KM, Ludwig N, Whiteside TL. Transport of extracellular vesicles across the Blood-brain barrier: brain pharmacokinetics and effects of inflammation. Int J Mol Sci. 2020;21(12):4407. https:\/\/doi.org\/10.3390\/ijms21124407.","journal-title":"Int J Mol Sci"},{"issue":"2","key":"3567_CR48","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1111\/imcb.025","volume":"96","author":"MC Gjelstrup","year":"2017","unstructured":"Gjelstrup MC, Stilund M, Petersen T, M\u00f8ller H, Petersen EL, Christensen T. Subsets of activated monocytes and markers of inflammation in incipient and progressed multiple sclerosis. Immunol Cell Biol. 2017;96(2):160\u201374. https:\/\/doi.org\/10.1111\/imcb.025.","journal-title":"Immunol Cell Biol"},{"key":"3567_CR49","doi-asserted-by":"publisher","first-page":"642384","DOI":"10.3389\/fnins.2021","volume":"15","author":"C Ferreira-Atuesta","year":"2021","unstructured":"Ferreira-Atuesta C, Reyes S, Giovanonni G, Gnanapavan S. The evolution of neurofilament light chain in multiple sclerosis. Front Neurosci. 2021;15:642384. https:\/\/doi.org\/10.3389\/fnins.2021.","journal-title":"Front Neurosci"},{"issue":"6","key":"3567_CR50","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1080\/17582024.2024.2421738","volume":"14","author":"MCA Virata","year":"2024","unstructured":"Virata MCA, Catahay JA, Lippi G, Henry BM. Neurofilament light chain: a biomarker at the crossroads of clarity and confusion for gene-directed therapies. Neurodegener Dis Manag. 2024;14(6):227\u201339. https:\/\/doi.org\/10.1080\/17582024.2024.2421738.","journal-title":"Neurodegener Dis Manag"},{"issue":"1","key":"3567_CR51","doi-asserted-by":"publisher","first-page":"e200055","DOI":"10.1212\/NXI.0000000000200055","volume":"10","author":"F Steffen","year":"2023","unstructured":"Steffen F, Uphaus T, Ripfel N, Fleischer V, Schraad M, Gonzalez-Escamilla G, et al. Serum neurofilament identifies patients with multiple sclerosis with severe focal axonal damage in a 6-year longitudinal cohort. Neurol Neuroimmunol Neuroinflamm. 2023;10(1):e200055. https:\/\/doi.org\/10.1212\/NXI.0000000000200055.","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"6","key":"3567_CR52","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1007\/s00415-025-13093-1","volume":"272","author":"MS Freedman","year":"2025","unstructured":"Freedman MS, Abdelhak A, Bhutani MK, Freeman J, Gnanapavan S, Hussain S, et al. The role of serum neurofilament light (sNfL) as a biomarker in multiple sclerosis: insights from a systematic review. J Neurol. 2025;272(6):400. https:\/\/doi.org\/10.1007\/s00415-025-13093-1.","journal-title":"J Neurol"}],"container-title":["Journal of Neuroinflammation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12974-025-03567-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12974-025-03567-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12974-025-03567-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T00:03:39Z","timestamp":1761091419000},"score":1,"resource":{"primary":{"URL":"https:\/\/jneuroinflammation.biomedcentral.com\/articles\/10.1186\/s12974-025-03567-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,21]]},"references-count":52,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3567"],"URL":"https:\/\/doi.org\/10.1186\/s12974-025-03567-4","relation":{},"ISSN":["1742-2094"],"issn-type":[{"value":"1742-2094","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,21]]},"assertion":[{"value":"7 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Institutional Review Board for Research at the American University of Beirut (protocol number IM.SK1.08), and all participants provided written informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"238"}}